美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Artelo Biosciences, Inc.

0.0056

0.0000

成交量：- -

成交額：- -

市值：1.87萬

市盈率：0.00

高：0.0056

開：0.0056

低：0.0056

收：0.0056

52周最高：0.0056

52周最低：0.0056

股本：334.74萬

流通股本：235.21萬

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-3.1338

每股收益(LYR):-1.5020

淨資產收益率：943.26%

總資產收益率：-314.86%

市淨率：--

市盈率(LYR):0.00

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Artelo Biosciences, Inc.

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.artelobio.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Artelo Biosciences, Inc.於2011年5月2日在內華達州註冊成立。該公司是一家臨床生物製藥公司，致力於開發和商業化旨在調節內源性信號通路的治療方法，包括內源性大麻素系統（“ ECS”），形成整個身體生化通信網絡的一系列受體和神經遞質。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/ARTLW/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ARTLW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARTLW\",,,,,undefined,":{"symbol":"ARTLW","market":"US","secType":"STK","nameCN":"Artelo Biosciences, Inc.","latestPrice":0.0056,"timestamp":1772053200000,"preClose":0.0056,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":2352098,"shares":3347419,"eps":-3.1338,"marketStatus":"盤前交易","change":0,"latestTime":"02-26 06:24:12 EST","open":0.0056,"high":0.0056,"low":0.0056,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-3.1338,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1772116200000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":0.0056,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARTLW\",,,,,undefined,":{"symbol":"ARTLW","floatShares":2352098,"roa":"-314.86%","roe":"943.26%","lyrEps":-1.501975,"shares":3347419,"dividePrice":0,"high":0.0056,"amplitude":0,"preClose":0.0056,"low":0.0056,"week52Low":0.0056,"pbRate":"--","week52High":0.0056,"institutionHeld":0,"latestPrice":0.0056,"eps":-3.1338,"divideRate":0,"volume":0,"delay":0,"ttmEps":-3.1338,"open":0.0056,"prevYearClose":0.0056,"prevWeekClose":0.0056,"prevMonthClose":0.0056,"prevQuarterClose":0.0056,"fiveDayClose":0.0056,"twentyDayClose":0.0056,"sixtyDayClose":0.0056},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ARTLW\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-06-18","symbol":"ARTLW","reason":null,"defaultRemindTime":1718717400000,"announcedDate":"2024-06-17","type":"delisting","dateTimestamp":1718683200000},{"market":"US","date":"2022-05-12","symbol":"ARTLW","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1652328000000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2022-01-12","symbol":"ARTLW","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1641963600000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ARTLW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ARTLW\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.artelobio.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.01},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0198},{"period":"6month","weight":0.0746},{"period":"1year","weight":0.1664},{"period":"ytd","weight":0.0165}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Artelo Biosciences, Inc.於2011年5月2日在內華達州註冊成立。該公司是一家臨床生物製藥公司，致力於開發和商業化旨在調節內源性信號通路的治療方法，包括內源性大麻素系統（“ ECS”），形成整個身體生化通信網絡的一系列受體和神經遞質。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.029596},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.098841},{"month":3,"riseRate":0.666667,"avgChangeRate":0.193144},{"month":4,"riseRate":0,"avgChangeRate":-0.232998},{"month":5,"riseRate":0.666667,"avgChangeRate":0.720236},{"month":6,"riseRate":0.166667,"avgChangeRate":-0.271091},{"month":7,"riseRate":0.285714,"avgChangeRate":0.032013},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.010256},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.098563},{"month":10,"riseRate":0.142857,"avgChangeRate":-0.090529},{"month":11,"riseRate":0.428571,"avgChangeRate":0.08353},{"month":12,"riseRate":0.428571,"avgChangeRate":0.504405}],"exchange":"NASDAQ","name":"Artelo Biosciences, Inc.","nameEN":"Artelo Biosciences, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ARTLW\",market:\"US\",,,undefined,":null}}